News

Palantir Technologies shares climbed Thursday after the analytics software provider said it extended a contract with the U.S. Army that could be worth $618.9 million.

(Bloomberg) -- If anything glitters in China’s otherwise dour retail jewelery landscape, chances are it just might be from Laopu Gold Co.Most Read from BloombergNew York City’s Historic Preservation Movement Is Having a Midlife CrisisNYPD Car Chases Are Becoming More Frequent — and More DangerousDakar’s Air Quality Plummets as Saharan Dust Descends on SenegalThe Bejing-based jeweler, whose Chinese name translates to “old shop,” is luring shoppers as it outshines market leader Chow Tai Fook Jewel

Global ETF assets reached $15.1 trillion in 2024, as investors embraced a record number of new launches and active management strategies, according to a new Bank of America report.

Conagra Brands shares slid Thursday after the food giant lowered its profit outlook, citing a "challenging consumer environment."

It has been feast or famine for the airline industry this year. An uneven merger landscape had a ripple effect on several players, and a sector-wide shift towards the premium end of the market left budget carriers scrambling to rethink their business models. That chaos showed up in stock prices, which ranged from nearly triple-digit losses to triple-digit gains.

The Federal Reserve's hawkish comments about uncertainty in the rate path ahead spooked investors.

Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and diabetes will need to phase out their versions next year under a federal decision issued Thursday. The Food and Drug Administration said that a nationwide shortage of Eli Lilly’s Zepbound and Mounjaro has been resolved, eliminating the need for copycat versions of the drugs that have become wildly popular with Americans trying to lose weight. The decision is a win for Lilly — which had been pressing the FDA to take the step for months — and is expected to impact how patients access the drugs, including how much they pay.